Crystalline form of Remdesivir
AssigneeApotex Inc.
InventorsFabio E. S. Souza, Alexander J. Stirk, Allan W. Rey
Life of this patent
Estimating the term…
Abstract
The present invention provides a novel crystalline form of remdesivir, remdesivir Form APO-I, including remdesivir and dimethyl sulfoxide, compositions and processes for the preparation thereof, the use of this crystalline form in the treatment of a viral infection, and methods of treating viral infections using the same, and in particular, a viral infection caused by Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2).
Claims21
A crystalline form of remdesivir comprising remdesivir and dimethyl sulfoxide.
A crystalline form of remdesivir comprising remdesivir and dimethyl sulfoxide characterized by a PXRD diffractogram comprising peaks, expressed in degrees 2θ (±0.2°), at 4.0°, 17.0° and 20.3°.
Dependencies are inferred from the claim text.